CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 10.0

ph-index = 9

Forward Citations = 284(Granted Patents)

Location History:

Ushiku, JP (2005 - 2006)
Ibaraki, JP (1991 - 2007)
Tsukuba, JP (1996 - 2013)

Company Filing History:

22 out of 677

Eisai Company, Limited

patents

3 out of 527

Eisai R&d Management Co., Ltd.

patents

Years Active: 1991-2013

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8530654 - Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid (2013-09-10),

2. 7939540 - 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives (2011-05-10),

3. 7807690 - 2,3-dihydro-iminoisoindole derivatives (2010-10-05),

4. 7189717 - Medicinal compositions promoting bowel movement (2007-03-13),

5. 7160892 - Pyrimidone compounds and pharmaceutical compositions containing the same (2007-01-09),

6. RE39112 - Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes (2006-05-29),

7. 6916837 - Amidino derivatives and anticoagulants and thrombosis therapeutic agents containing them (2005-07-12),

8. 6841549 - Condensed imidazole compounds and a therapeutic agent for diabetes mellitus (2005-01-11),

9. 6750232 - 2-aminopyridine compounds and use thereof as drugs (2004-06-15),

10. 6579868 - Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes (2003-06-17),

11. 5843918 - Anti-endotoxin compounds (1998-12-01),

12. 5756718 - Anti-endotoxin compounds (1998-05-26),

13. 5612476 - Anti-endotoxin compounds (1997-03-18),

14. 5530113 - Anti-endotoxin compounds (1996-06-25),

15. 5482937 - 1,4-diazepine derivative and its pharmaceutical use (1996-01-09),

Title: Innovative Contributions of Osamu Asano in Pharmaceutical Patents

Introduction

Osamu Asano is a distinguished inventor based in Tsukuba, Japan, known for his significant contributions to the pharmaceutical field. With an impressive portfolio of 25 patents, he has dedicated his career to the development of innovative compounds aimed at addressing various allergic diseases.

Latest Patents

Osamu Asano's latest patents showcase his focus on creating advanced medicinal compounds. One notable patent involves crystals and amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid. This innovation provides crystals, amorphous substances, salts, and hydrates with PDE4 inhibitory action, which are beneficial for treating allergic diseases such as atopic dermatitis. Another significant patent revolves around 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives. This compound effectively alleviates itching caused by atopic diseases, highlighting the therapeutic potential of these formulations.

Career Highlights

Throughout his career, Osamu Asano has been associated with prestigious companies like Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work at these organizations has significantly advanced the field of medicinal chemistry, contributing to the discovery of novel therapeutic agents.

Collaborations

Asano's efforts have been enhanced through collaborations with notable coworkers such as Shuhei Miyazawa and Naoyuki Shimomura. Together, they have worked on various projects that aim to innovate and improve treatments for allergic conditions, showcasing a strong teamwork ethic in research and development.

Conclusion

In conclusion, Osamu Asano stands out as a prominent inventor in the pharmaceutical industry, with a valuable portfolio of patents that address critical health issues. His dedication to innovation and his collaborations with esteemed colleagues underscore his commitment to advancing medical science for the benefit of patients suffering from allergic diseases.

This text is generated by artificial intelligence and may not be accurate.